Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 12 studies | 54% ± 21% | |
GABAergic neuron | 11 studies | 45% ± 20% | |
oligodendrocyte precursor cell | 7 studies | 29% ± 10% | |
interneuron | 6 studies | 46% ± 20% | |
retinal ganglion cell | 5 studies | 48% ± 31% | |
neuron | 4 studies | 37% ± 10% | |
astrocyte | 4 studies | 31% ± 21% | |
endothelial cell | 3 studies | 40% ± 13% | |
GABAergic interneuron | 3 studies | 27% ± 8% | |
microglial cell | 3 studies | 35% ± 14% | |
glycinergic amacrine cell | 3 studies | 27% ± 7% | |
amacrine cell | 3 studies | 47% ± 24% | |
neural progenitor cell | 3 studies | 42% ± 31% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 13 studies | 39% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 94% | 616.12 | 2482 / 2642 | 65% | 3.04 | 458 / 705 |
prostate | 84% | 192.41 | 205 / 245 | 49% | 1.80 | 248 / 502 |
thymus | 96% | 219.09 | 625 / 653 | 9% | 0.34 | 52 / 605 |
ovary | 83% | 168.48 | 149 / 180 | 0% | 0.00 | 1 / 430 |
stomach | 66% | 76.49 | 236 / 359 | 1% | 0.01 | 3 / 286 |
skin | 12% | 7.34 | 211 / 1809 | 46% | 1.65 | 216 / 472 |
bladder | 48% | 57.10 | 10 / 21 | 1% | 0.07 | 4 / 504 |
uterus | 42% | 74.69 | 72 / 170 | 4% | 0.13 | 19 / 459 |
intestine | 40% | 30.11 | 382 / 966 | 0% | 0.00 | 1 / 527 |
adrenal gland | 9% | 8.54 | 23 / 258 | 26% | 1.71 | 59 / 230 |
heart | 34% | 39.71 | 297 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 30% | 0.56 | 24 / 80 |
blood vessel | 30% | 26.16 | 399 / 1335 | 0% | 0 | 0 / 0 |
adipose | 20% | 16.59 | 246 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 19% | 13.42 | 273 / 1445 | 1% | 0.01 | 2 / 183 |
spleen | 17% | 11.68 | 41 / 241 | 0% | 0 | 0 / 0 |
breast | 15% | 10.93 | 71 / 459 | 0% | 0.01 | 2 / 1118 |
lung | 5% | 3.45 | 30 / 578 | 3% | 0.20 | 31 / 1155 |
kidney | 3% | 2.74 | 3 / 89 | 1% | 0.15 | 13 / 901 |
pancreas | 0% | 0 | 0 / 328 | 3% | 0.28 | 5 / 178 |
liver | 0% | 0 | 0 / 226 | 1% | 0.06 | 6 / 406 |
muscle | 0% | 0.12 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032793 | Biological process | positive regulation of CREB transcription factor activity |
GO_0048013 | Biological process | ephrin receptor signaling pathway |
GO_0021766 | Biological process | hippocampus development |
GO_0019933 | Biological process | cAMP-mediated signaling |
GO_0043087 | Biological process | regulation of GTPase activity |
GO_0061178 | Biological process | regulation of insulin secretion involved in cellular response to glucose stimulus |
GO_0048666 | Biological process | neuron development |
GO_0006468 | Biological process | protein phosphorylation |
GO_0032956 | Biological process | regulation of actin cytoskeleton organization |
GO_0007411 | Biological process | axon guidance |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0043025 | Cellular component | neuronal cell body |
GO_0030425 | Cellular component | dendrite |
GO_0030424 | Cellular component | axon |
GO_0005791 | Cellular component | rough endoplasmic reticulum |
GO_0005004 | Molecular function | GPI-linked ephrin receptor activity |
GO_0005003 | Molecular function | ephrin receptor activity |
GO_0005005 | Molecular function | transmembrane-ephrin receptor activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | EPHA5 |
Protein name | receptor protein-tyrosine kinase (EC 2.7.10.1) Ephrin type-A receptor 5 (EC 2.7.10.1) (Brain-specific kinase) (EPH homology kinase 1) (EHK-1) (EPH-like kinase 7) (EK7) (hEK7) |
Synonyms | hCG_1810817 BSK EHK1 HEK7 TYRO4 |
Description | FUNCTION: Receptor tyrosine kinase which binds promiscuously GPI-anchored ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Among GPI-anchored ephrin-A ligands, EFNA5 most probably constitutes the cognate/functional ligand for EPHA5. Functions as an axon guidance molecule during development and may be involved in the development of the retinotectal, entorhino-hippocampal and hippocamposeptal pathways. Together with EFNA5 plays also a role in synaptic plasticity in adult brain through regulation of synaptogenesis. In addition to its function in the nervous system, the interaction of EPHA5 with EFNA5 mediates communication between pancreatic islet cells to regulate glucose-stimulated insulin secretion (By similarity). . |
Accessions | B7ZKJ3 ENST00000273854.7 [P54756-1] ENST00000511294.1 B7ZKW7 ENST00000354839.8 [P54756-2] ENST00000613740.5 ENST00000432638.6 A0A384MU00 P54756 F8VP57 ENST00000622150.4 F8W9W0 |